is tirzepatide approved FDA Grants a New Indication for Obesity Management The Best GLP-1 Drug on

Feng Y, Demehri FR, Xiao W, Tsai YH, Jones JC, Brindley CD, Threadgill DW, Holst JJ, Hartmann B, Barrett TA, Teitelbaum DH, Dempsey PJ (2017) Interdependency of EGF and GLP-2 signaling in attenuating mucosal atrophy in a mouse model of parenteral nutrition

Medications are HSA/FSA eligible, and no membership fee applies

Tirzepatide raises resting heart rate by around 1.8 beats per minute on average, but the SURMOUNT trial programme didnt show an increase in arrhythmias or major adverse cardiac events compared to placebo

Interferon- initiates type 1 diabetes in nonobese diabetic mice

Today, were talking about Apretude (cabotegravir), an injectable form of PrEP

WADA Anti-Doping Education and Learning Platform